Julie Demeritt
AstraZeneca (Brazil)(BR)
Publications by Year
Research Areas
Synthesis and Biological Evaluation, Synthesis and biological activity, Cancer therapeutics and mechanisms, Tuberculosis Research and Epidemiology, Antibiotic Resistance in Bacteria
Most-Cited Works
- → Pyrrolamide DNA Gyrase Inhibitors: Fragment-Based Nuclear Magnetic Resonance Screening To Identify Antibacterial Agents(2011)134 cited
- → Development and Scale-up of a Biocatalytic Process To Form a Chiral Sulfoxide(2017)62 cited
- → Biochemical characterization of an inhibitor of Escherichia coli UDP-N-acetylmuramyl-l-alanine ligase(2003)40 cited
- → Discovery of AZD3147: A Potent, Selective Dual Inhibitor of mTORC1 and mTORC2(2015)28 cited
- → Discovery of 4,6-disubstituted pyrimidines as potent inhibitors of the heat shock factor 1 (HSF1) stress pathway and CDK9(2016)21 cited
- → Synthesis of Indole-Dihydroisoquinoline Sulfonyl Ureas via Three-Component Reactions(2018)6 cited
- → Expedient synthesis of biologically important sulfonylmethyl pyrimidines(2014)4 cited
- → ChemInform Abstract: Expedient Synthesis of Biologically Important Sulfonylmethyl Pyrimidines.(2014)
- → CCDC 1019570: Experimental Crystal Structure Determination(2015)
- → Correction: Discovery of 4,6-disubstituted pyrimidines as potent inhibitors of the heat shock factor 1 (HSF1) stress pathway and CDK9. See DOI: 10.1039/c6md00159a(2016)